Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients
Year: 2022
Type: erratum
Abstract: Following publication of the original article [1], the authors flagged the following error in the '3. Formula to estimate the contralateral breast cancer risk using PredictCBC-2.0A' section of additional file 1: ‘+ 0.065 × I[Radiotherapy to the breast = yes]’ had been written in place of ‘− 0.065 × I[Radiotherapy to the breast = yes]‘. The file has since been corrected. The authors thank you for reading and apologize for any inconvenience caused.
Source: Breast Cancer Research
Authors: Daniele Giardiello, Maartje J. Hooning, Michael Hauptmann, Renske Keeman, B. A. M. Heemskerk-Gerritsen, Heiko Becher, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Nicola J. Camp, Kamila Czene, Peter Devilee, Diana M. Eccles, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Montserrat García-Closas, Christopher A. Haiman, Ute Hamann, John L. Hopper, Anna Jakubowska, Floor E. Leeuwen, Annika Lindblom, Jan Lubiński, Sara Margolin, Maria Elena Martinez, Heli Nevanlinna, Ines Nevelsteen, Saskia Pelders, Paul D. P. Pharoah, Sabine Siesling, Melissa C. Southey, Annemieke H. van der Hout, Liselotte P. van Hest, Jenny Chang-Claude, Per Hall, Douglas F. Easton, Ewout W. Steyerberg, Marjanka K. Schmidt
Institutions: Eurac Research, Leiden University Medical Center, The Netherlands Cancer Institute, Institute for Biomedicine, University of Lübeck, Erasmus MC Cancer Institute, Medizinische Hochschule Brandenburg Theodor Fontane, University Medical Center Hamburg-Eppendorf, University of Helsinki, Helsinki University Hospital, Örebro University Hospital, University of Copenhagen, Herlev Hospital, Copenhagen University Hospital, Gentofte Hospital, University of Cambridge, University of Utah, Huntsman Cancer Institute, Karolinska Institutet, University of Southampton, University of California, Los Angeles, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen, National Institutes of Health, Edinburgh Cancer Research, National Cancer Institute, Division of Cancer Epidemiology and Genetics, University of Edinburgh, University of Southern California, German Cancer Research Center, The University of Melbourne, Pomeranian Medical University, Karolinska University Hospital, Stockholm South General Hospital, University of California San Diego, Moores Cancer Center, Universitair Ziekenhuis Leuven, Netherlands Comprehensive Cancer Organisation, University of Twente, Cancer Council Victoria, Monash Health, Monash University, University Medical Center Groningen, University of Groningen, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, University Cancer Center Hamburg
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,590
Funders: U.S. Department of Health and Human Services, University of Southern California, Helsingin Yliopisto, Deutsches Krebsforschungszentrum, Amsterdam University Medical Centers, Cancer Research UK, University of Edinburgh, Monash University, University of Melbourne, Vrije Universiteit Amsterdam, University of Twente, Gentofte Hospital, Karolinska Institutet, Universitair Medisch Centrum Groningen, Pomorski Uniwersytet Medyczny W Szczecinie, National Institutes of Health, University of California, San Diego, Cancer Council Victoria, Universitätsklinikum Hamburg-Eppendorf, National Cancer Institute
OpenAlex ID: W4309745955